Effectiveness of COVID-19 vaccines: findings from real world studies.
作者信息
Henry David A, Jones Mark A, Stehlik Paulina, Glasziou Paul P
机构信息
Institute for Evidence-Based Healthcare, Bond University, Gold Coast, QLD.
Gold Coast University Hospital and Health Service, Gold Coast, QLD.
出版信息
Med J Aust. 2021 Aug 16;215(4):149-151.e1. doi: 10.5694/mja2.51182. Epub 2021 Jul 22.
Abstract
摘要
相似文献
1
Effectiveness of COVID-19 vaccines: findings from real world studies.新冠疫苗的有效性：来自真实世界研究的结果。
Med J Aust. 2021 Aug 16;215(4):149-151.e1. doi: 10.5694/mja2.51182. Epub 2021 Jul 22.
2
Are COVID vaccination programmes working? Scientists seek first clues.新冠疫苗接种计划是否有效？科学家们寻找初步线索。
Nature. 2021 Jan;589(7843):504-505. doi: 10.1038/d41586-021-00140-w.
3
COVID-19 vaccine mandates in Europe.欧洲的新冠疫苗强制接种规定。
Lancet Infect Dis. 2022 Jan;22(1):27-28. doi: 10.1016/S1473-3099(21)00776-3.
4
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
5
Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas.佛罗里达州和得克萨斯州新冠疫苗接种率未达最佳水平的影响。
Lancet Infect Dis. 2021 Nov;21(11):1493-1494. doi: 10.1016/S1473-3099(21)00620-4. Epub 2021 Oct 7.
6
Randomized COVID-19 vaccination rollout can offer direct real-world evidence.随机的 COVID-19 疫苗接种推广可以提供直接的真实世界证据。
J Clin Epidemiol. 2021 Oct;138:199-202. doi: 10.1016/j.jclinepi.2021.05.014. Epub 2021 May 25.
7
Why Oxford's positive COVID vaccine results are puzzling scientists.为何牛津大学新冠疫苗的阳性结果令科学家们感到困惑。
Nature. 2020 Dec;588(7836):16-18. doi: 10.1038/d41586-020-03326-w.
8
[COVID-19 Vaccination for Cancer Patients: Progress and Preliminary Recommendations].[癌症患者的 COVID-19 疫苗接种：进展与初步建议]
Zhongguo Fei Ai Za Zhi. 2021 Jun 20;24(6):377-383. doi: 10.3779/j.issn.1009-3419.2021.101.18. Epub 2021 May 24.
9
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.COVID-19 疫苗在预防≥65 岁成年人住院方面的有效性 - COVID-NET，13 个州，2021 年 2 月至 4 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093. doi: 10.15585/mmwr.mm7032e3.
10
How COVID vaccines shaped 2021 in eight powerful charts.新冠疫苗如何通过八张有力图表塑造了2021年。
Nature. 2021 Dec;600(7890):580-583. doi: 10.1038/d41586-021-03686-x.
引用本文的文献
1
Efficacy and effectiveness of COVID-19 vaccines in Africa: A systematic review.非洲 COVID-19 疫苗的有效性和效果：系统评价。
PLoS One. 2024 Jun 28;19(6):e0306309. doi: 10.1371/journal.pone.0306309. eCollection 2024.
2
Vaccination and Its Impact on Lung Involvement in COVID-19 Patients: A Retrospective Study in India.疫苗接种及其对新冠病毒肺炎患者肺部受累情况的影响：印度的一项回顾性研究
Cureus. 2024 Apr 24;16(4):e58904. doi: 10.7759/cureus.58904. eCollection 2024 Apr.
3
Risk factors for progressing to critical illness in patients with hospital-acquired COVID-19.医院获得性 COVID-19 患者进展为重症的危险因素。
Korean J Intern Med. 2024 May;39(3):477-487. doi: 10.3904/kjim.2023.347. Epub 2024 Apr 18.
4
Potential Risk Factors to COVID-19 Severity: Comparison of SARS-CoV-2 Delta- and Omicron-Dominant Periods.新冠病毒严重程度的潜在风险因素：德尔塔和奥密克戎主导期的 SARS-CoV-2 比较。
Int J Environ Res Public Health. 2024 Mar 10;21(3):322. doi: 10.3390/ijerph21030322.
5
ution of the data and methods in real-world COVID-19 vaccine effectiveness studies on mortality: a oping eview protocol.在真实世界 COVID-19 疫苗效果研究中关于死亡率的数据和方法的评价：一项系统综述方案。
BMJ Open. 2024 Mar 19;14(3):e079071. doi: 10.1136/bmjopen-2023-079071.
6
Vaccine hesitancy for the COVID-19 vaccine booster dose among nursing home staff fully vaccinated with the primary vaccination course in Belgium.比利时已完成新冠疫苗基础免疫接种程序的养老院工作人员对新冠疫苗加强针的犹豫态度。
Vaccine X. 2024 Jan 30;16:100453. doi: 10.1016/j.jvacx.2024.100453. eCollection 2024 Jan.
7
Mandatory COVID Vaccination: Perspectives from Graduate Allied Health Students at a Mid-size University in the United States.强制接种新冠疫苗：美国一所中型大学的健康相关专业研究生的观点
J Community Health. 2024 Apr;49(2):355-365. doi: 10.1007/s10900-023-01297-3. Epub 2023 Nov 22.
8
Vaccine effectiveness of COVID-19 and rebound in the real world.新冠病毒疫苗有效性和真实世界反弹的研究
Clin Exp Med. 2023 Dec;23(8):4975-4983. doi: 10.1007/s10238-023-01204-z. Epub 2023 Nov 16.
9
A caputo fractional order epidemic model for evaluating the effectiveness of high-risk quarantine and vaccination strategies on the spread of COVID-19.一个用于评估高风险隔离和疫苗接种策略对COVID-19传播有效性的卡普托分数阶流行病模型。
Healthc Anal (N Y). 2023 Nov;3:100179. doi: 10.1016/j.health.2023.100179. Epub 2023 Apr 20.
10
Expensive seems better: The price of a non-effective drug modulates its perceived efficacy.昂贵似乎更好：无效药物的价格调节了其感知疗效。
Cogn Res Princ Implic. 2023 Jan 26;8(1):8. doi: 10.1186/s41235-023-00463-4.
本文引用的文献
1
High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population - first results from a cohort study in Southern Sweden.两剂 BNT162b2 疫苗对工作年龄人群预防 COVID-19 的高保护水平 - 来自瑞典南部队列研究的初步结果。
Infect Dis (Lond). 2022 Feb;54(2):128-133. doi: 10.1080/23744235.2021.1982144. Epub 2021 Sep 29.
2
FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system.FDA 授权的 mRNA COVID-19 疫苗根据多州医疗系统综合的真实世界证据有效。
Med. 2021 Aug 13;2(8):979-992.e8. doi: 10.1016/j.medj.2021.06.007. Epub 2021 Jun 29.
3
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.苏格兰的新冠病毒德尔塔变异株：人口统计学、住院风险及疫苗有效性
Lancet. 2021 Jun 26;397(10293):2461-2462. doi: 10.1016/S0140-6736(21)01358-1. Epub 2021 Jun 14.
4
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.辉瑞-生物科技疫苗和牛津-阿斯利康疫苗对英格兰老年人新冠病毒相关症状、住院及死亡率的有效性：检测阴性病例对照研究
BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088.
5
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.英国COVID症状研究应用程序使用者接种疫苗后的疫苗副作用和SARS-CoV-2感染：一项前瞻性观察研究。
Lancet Infect Dis. 2021 Jul;21(7):939-949. doi: 10.1016/S1473-3099(21)00224-3. Epub 2021 Apr 27.
6
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.英格兰医护人员的 COVID-19 疫苗接种率和 BNT162b2 mRNA 疫苗对感染的有效性（SIREN）：一项前瞻性、多中心、队列研究。
Lancet. 2021 May 8;397(10286):1725-1735. doi: 10.1016/S0140-6736(21)00790-X. Epub 2021 Apr 23.
7
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.苏格兰首次大规模 COVID-19 疫苗接种和 COVID-19 住院的临时发现：一项全国性前瞻性队列研究。
Lancet. 2021 May 1;397(10285):1646-1657. doi: 10.1016/S0140-6736(21)00677-2. Epub 2021 Apr 23.
8
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021.BNT162b2 疫苗和 mRNA-1273 新冠疫苗在预防医护人员、第一响应者和其他必要及一线工作人员感染 SARS-CoV-2 中的疫苗有效性的临时估计-2020 年 12 月至 2021 年 3 月美国 8 个地点。
MMWR Morb Mortal Wkly Rep. 2021 Apr 2;70(13):495-500. doi: 10.15585/mmwr.mm7013e3.
9
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
10
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.一剂接种和加强针接种时间对 ChAdOx1 nCoV-19（阿斯利康）疫苗免疫原性和有效性的影响：四项随机试验的 pooled 分析。
Lancet. 2021 Mar 6;397(10277):881-891. doi: 10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19.
Zotero 插件